Answers are grounded in this paper and cite their sources.
A two treatment response adaptive design is developed for phase III clinical trials with ordinal categorical treatment outcome using Goodman-Kruskal measure of association. Properties of the proposed design are studied both empirically and theoretically and the acceptability is further illustrated using two real data-sets; one from a clinical trial with trauma patients and the other from a trial with patients having rheumatoid arthritis.
No takes yet. Share an insight, caveat, or question.
Biswas et al. (2018) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: